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DBackground: The frequency and impact of medical errors during staged palliation are unknown.
Methods: All patients with hypoplastic left heart syndrome and physiologic equivalents (N ¼ 191) who under-
went staged palliation (2001-2011) were studied. Stage 1, interstage, and stage 2 were reviewed to identify
diagnostic, technical, judgment, and management errors. The impact of errors on transplant-free survival was
examined by parametric competing risks and risk-adjusted regressions using bootstrapping.
Results: Stage 1 (N ¼ 191) errors (n ¼ 111, 58%) were common and predominantly intraoperative (n ¼ 84,
44%) or postoperative (n¼ 43, 23%). Postoperative errors were determinants of death/transplant (hazard ratio,
1.7; P ¼ .01), whereas technical errors (n ¼ 65, 34%) were not, but they delayed recovery and discharge (extra
24 days approximately, P ¼ .0024). Postoperative stage 1 errors led to decrements in total strategy success of
approximately 30% (78% vs 48%, P ¼ .004). Stage 2 (N ¼ 134) errors (n ¼ 66, 49%) were common. Intra-
operative errors were the most prevalent (n ¼ 61, 46%) but did not compromise survival. Postoperative errors
(n ¼ 11, 8%) were determinants of death/transplant (hazard ratio, 2.4; P<.0001). Interstage errors (n ¼ 21,
16%) led to twice the intensive care unit stay (16 vs 7 days, P< .0001) and hospital stay (30 vs 17 days,
P<.02) after stage 2. Overall, a child presenting with ideal morphology and managed with no postoperative
errors at stage 1 or 2 would have a predicted late survival in excess of 80%.
Conclusions: Technical errors are common and delay recovery. Their effects on survival are mitigated. Intra-
operative judgment errors are associated with strategy failure in a univariate model and lead to increased post-
operative errors in a multivariate model. Postoperative errors are independently associated with a decrease in
univentricular strategy survival. (J Thorac Cardiovasc Surg 2013;145:1465-75)Hypoplastic left heart syndrome (HLHS) and physiologic
equivalents are composed of various types of complex anat-
omy and physiology. The surgical options and medical
treatment are similarly complex. Because medical com-
plexity is a known association with medical error,1 it is con-
ceivable that treatment errors occurring in patients with
HLHS may lead to deleterious outcomes.
Up to one third of children undergoing univentricular pal-
liation for HLHS will die or undergo cardiac transplantation
before transitioning to a cavopulmonary connection.2
Efforts to understand strategy failures have focused on mor-
phologic and functional risk factors. Such risks are now
well understood but are generally immutable. Efforts havee Labatt Family Heart Centre, The Hospital for Sick Children, University of
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The Journal of Thoracic and Caralso focused on refining surgical techniques and preopera-
tive and postoperative care. Levels of improvement to out-
comes have been disappointing in the last decade.2-4
The purpose of this study was to evaluate patient course
for errors that might affect patient outcome. We hypothe-
sized that human errors could translate into delayed recov-
ery and increased risk of death or transplantation. Such
errors represent a realistic opportunity for improving out-
comes as they might be predicted, avoided, or mitigated.
Study aims were to (1) review and identify preoperative, in-
traoperative, and postoperative errors (PEs) in diagnosis,
judgment, clinical management, or surgical technique at
both stages 1 and 2; (2) explore the impact of these medical
errors on recovery and transplant-free survival; and (3)
define patterns of errors among the surgical strategies used.
MATERIALS AND METHODS
Overview
This investigation studied all 191 infants in whom staged surgical pal-
liation for HLHS (or analogous physiology) was attempted between Janu-
ary 2001 and January 2011 at The Hospital for Sick Children, Toronto.
Surgical strategies included the conventional Norwood operation (includ-
ing both the modified Blalock–Taussig shunt and right ventricular to pul-
monary artery conduit [Sano]) or hybrid approaches (with or without
reverse Blalock–Taussig shunt) that have been selectively used for the
last 7 years. Hybrid procedures performed to achieve hemodynamicdiovascular Surgery c Volume 145, Number 6 1465
Abbreviations and Acronyms
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ICU ¼ intensive care unit
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Dstability while awaiting transplant were excluded.5 Each patient’s course
was summarized for the study time frame. Charts were reviewed by senior
clinical fellows (F.J., V.A., Y.K.) who summarized individual patient hos-
pitalization and outpatient courses into objective abstracts. The abstracts
comprised complete anatomic details, imaging reports, decision-making
process, operative or interventional details (including any revisions), post-
operative course (including hemodynamic support, ventilatory support
time, extubation or chest closure, and physiologic problems), transition
to the ward, residual lesions, discharge planning (including medication),
and outpatient follow-up. Electronic charts, including clinic letters, clinical
conference decision notes, echocardiography, diagnostic imaging, cathe-
terization and operative reports, perfusion records, intensive care and car-
diology ward daily progress notes, all paramedical therapists’ notes,
laboratory values (including mixed venous oxygen saturations and lactate
levels), and pathology reports, on every patient were reviewed until 10
months of age if on the staged surgical palliation pathway or until cardiac
transplantation or death. Follow-up was complete in all patients. Abstracts
were reviewed by a senior staff surgeon (G.S.V.) to identify and classify any
errors in diagnosis, judgment, technical performance, and management.
When required, questions from the reviewer were addressed by the abstrac-
tors and the case was reviewed again. Any finding that was less than
optimal (anatomic or physiologic), that was not considered to be part of
a ‘‘normal patient course’’ (or the primary presenting disease state), and
that occurred as a result of a provider decision or intervention was labeled
an error. Adverse events that did not result from a clinical decision or in-
tervention were not labeled errors, for example, the development of renal
dysfunction after an uncomplicated procedure would not be considered
an error, whereas the need to reopen a chest because of premature chest clo-
sure–related hemodynamic compromise would. For the purpose of this
study, we defined the optimal and normal course as follows: (1) preopera-
tive: intent to or manage to have preoperative stability (ie, if necrotizing en-
terocolitis, renal failure, or sepsis occurs, an allowance for recovery before
surgery). (2) intraoperative: anesthetic induction with hemodynamic stabil-
ity and line insertion without complication, 1 period of cardiac ischemia,
and cardiopulmonary bypass (including any intermittent circulatory arrest
and regional cerebral perfusion) for the operation. Chest closure may or
may not be performed. (3) postoperative: modest doses of inotropic and
vasodilatory support; no issues of tamponade or major bleeding; if open,
chest closure within 1 week and successful with 1 attempt; 1 successful
extubation attempt; no cardiac arrest; no use of extracorporeal membrane
oxygenation; no development of postoperative necrotizing enterocolitis
or sepsis; medically manageable Qp:Qs; and transition to the ward and
home without return and all occurring within a time frame of 4 to 5 weeks
or less. An optimal anatomic condition was intraoperative and postopera-
tive imaging demonstrating no arch obstruction, no shunt issues, no aorto-
pulmonary connection flow acceleration, no pulmonary artery stenosis, and
cardiac contractility that at least matched the preoperative state. For hybrid
stage I, pulmonary artery stenosis was part of the planned procedure. A
similar definition was used for stage II but with compressed timeframes
and the addition of mild plus or less atrioventricular valve regurgitation.
We defined an interstage optimal course to be no readmissions or interven-
tions required and no need for cardiac rescue. The timing of the error with
respect to time point in each patient’s course was noted. The link and the
sequence between errors, and the error impact on mortality and morbidity
were assessed clinically by performing root cause analysis. The strength of
causal link to each patient’s course was estimated as follows: (1) no link to1466 The Journal of Thoracic and Cardiovascular Surdeath, (2) possible link to death (ie, it is conceivably related but not likely),
(3) mild relation to death (ie, it had an influence but little), and (4) direct
relation to death. The impact of errors was explored in multivariate para-
metric competing risk models of transplant-free survival. The study was
approved by The Hospital for Sick Children research ethics board, and
consent requirement was waived.
Statistical Methodology
Survival analyses were performed via parametric time-related compet-
ing risks techniques using multiple hazard phases as previously
described.6,7 All analyses were undertaken using SAS statistical software
(SAS Institute Inc, Cary, NC) using parametric HAZARD macros (www.
clevelandclinic.org/heartcenter/hazard). After stage 1, every child is at
risk of transitioning to any of the mutually exclusive competing end
states of death, transplantation, or successful transition to stage 2. Each
of these end states can be modeled independently and subjected to risk-
hazard analysis. However, because transplantation represents failure of
strategy, it was combined with death as ‘‘failures‘‘ of surgical palliative
strategy.
Risk-Hazard Analyses
For risk-hazard analyses, variables were tested in a univariate fashion
and subsequently multivariable (risk-adjusted) fashion using parametric
automated forward stepwise regression. Variables were processed as previ-
ously described.7 All continuous variables were tested for transformations
that improved model fit. Reliability of variables reaching statistical signif-
icance (P<.05) was tested using bootstrap resampling in which automated
random training datasets are generated (N ¼ 1000) against which the vari-
ables are tested. Inclusion of the variable in approximately 50% or more of
training datasets is interpreted as an indicator of good reliability.8 Many
variables that reach statistical significance in clinical regression analyses
are poorly reliable in that they are not statistically significant when tested
in other similar datasets. Bootstrap resampling tests the ‘‘generalizability’’
of a variable to the wider study population by describing both its signifi-
cance and reliability.
Logistic and linear (forward stepwise) regression models were used to
identify statistically significant determinants of binary and continuous vari-
ables, respectively (SAS statistical software), which were then bootstrap
tested for reliability. For other descriptive statistics, comparisons or means
or proportions were made using the Student t test or Fisher exact test.RESULTS
Procedures and Outcomes
The study cohort of 191 infants had aortic atresia
(N ¼ 75; 40%), aortic stenosis (N ¼ 61; 32%), double-
inlet left ventricle/absent right atrioventricular connection
associated with transposition of the great arteries
(N ¼ 40; 21%), and unbalanced atrioventricular septal de-
fect (N¼ 15; 8%). All 191 infants underwent a stage 1 pro-
cedure (Norwood ¼ 142, 74%; hybrid ¼ 49, 26%).Stage 1
The Norwood operation was undertaken with a median
myocardial ischemic time of 62 minutes (31-250 minutes)
and the use of selective cerebral perfusion and intermittent
circulatory arrest. Pulmonary blood flow was via a modified
Blalock–Taussig shunt (N ¼ 116, 82%) or Sano modifica-
tion (N ¼ 26, 18%). Early in the decade, the Brawn all in
situ technique9 was used for arch reconstruction in 7gery c June 2013
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Dpatients. Subsequently, the interdigitating technique was
used.10 Intraoperative revisions were required in 42 patients
(30%), including shunt (N ¼ 24), pulmonary arteries
(N ¼ 11), Damus–Kaye–Stansel anastomosis (N ¼ 11),
and arch revision (N ¼ 9). Revisions were performed on
the basis of direct clinical concern or findings on intraoper-
ative echocardiography that were thought to be important to
clinical outcome. Intraoperative implementation of extra-
corporeal membrane oxygenation support was necessary
in 2 children. Hybrid stage 1 strategies were undertaken
as previously described with the selective use of a ‘‘reverse
Blalock–Taussig shunt’’ in 20 patients (40%) to protect
against retrograde arch malperfusion.11 Of all 191 stage 1
procedures, 34 patients (18%) required extracorporeal
membrane oxygenation support at some point in the postop-
erative period.
Outcomes after stage 1. Time-related outcomes after
stage 1 are shown in Figure 1. In-hospital mortality at stage
1 was 16% (N ¼ 31/191). Before stage 2, 11 other patients
(6%) died and 14 patients (7%) were referred for transplan-
tation. Successful transition to stage 2 occurred in 134
patients (70%).
Errors surrounding stage 1 procedure. Errors surround-
ing stage 1 affected 111 of the 191 patients (58%) and are
summarized in Table 1. Ten patients (5%) had a preopera-
tive error, 84 patients (44%) had intraoperative error, and
43 patients had postoperative error (23%). Intraoperative
errors were related to clinical judgment or technical perfor-
mance. The most common errors are presented in Table 2.
The 3 most common intraoperative judgment errors wereFIGURE 1. Competing outcomes after all 191 stage 1 interventions. Im-
mediately after stage 1, all 100% of infants are alive and have not yet tran-
sitioned to stage 2 or any other end state. Gradually with time, however,
children transition at different rates to one of several mutually exclusive
and competing end states: death, transplantation, or otherwise stage 2.
One year after stage 1, 74%  6% had successfully transitioned to stage
2, 21%  4% had died before stage 2, 6%  2% had undergone cardiac
transplantation, and an additional 1% had been accepted on the waiting list
for transplantation. Lines represent continuous point estimates of paramet-
ric models. HTX, Heart transplantation.
The Journal of Thoracic and Car(1) decision to close the chest with subsequent hemody-
namic compromise (N ¼ 10/191; 5%); (2) not recognizing
or addressing shunt inflow concern not related to the anas-
tomosis but to the particular anatomy of the patient (eg,
a very large or unusually small innominate artery that could
affect shunt flow) (N ¼ 9/191; 5%); and (3) selecting the
wrong size for a shunt considering the body surface area
of the patient (N ¼ 6/191; 3%). The 3 most common intra-
operative technical errors were related to (1) systemic-
pulmonary shunt construction (ie, anastomotic problem)
(N ¼ 21/191; 11%); (2) coronary artery malperfusion
(N ¼ 7/191; 4%); and (3) obstructive aortic arch recon-
struction (N ¼ 11/191; 6%). Most intraoperative errors
were not detected at the time—84% of judgment errors
(N ¼ 21/25) and 63% of technical errors (N ¼ 41/65)
went undetected. Of the technical errors, 27 were addressed
after recognition in the postoperative period (N ¼ 27/65;
42%). PEs occurred more commonly in the intensive care
setting (N ¼ 22/191; 12%) than during ward care (N ¼ 4/
191). The 3 most common errors in the intensive care unit
(ICU) were (1) a delay in recognizing or managing a clinical
scenario (eg, latent sepsis or low cardiac output syndrome)
(N ¼ 16/191; 8%); (2) a failed attempt of delayed sternal
closure (N ¼ 11/191; 6%); and (3) errors related to airway
devices and extubation (N ¼ 4/191; 2%). PEs were consid-
ered foreseeable in 77% of patients (N ¼ 33/43) after stage
1. Errors were defined as foreseeable when a patient’s pre-
ceding condition and available information to the clinician
might have predicted a less than optimal course. For exam-
ple, an intubated patient presents with a moderate and not
drained pleural effusion noted by the radiologist but not
by the clinical team that includes surgeons, intensivists,
and cardiologists (all according to the notes). The patient
is extubated, fails extubation, is reintubated, has a chest
tube inserted, and is reextubated within hours. That is,
a foreseeable error as recognition of the effusion before ex-
tubation might have led to a different approach to the pa-
tient. The effusion per se was an indirect complication of
the surgery but not an error. Of the 43 patients with a PE,
20 previously had an intraoperative error (47%). In multi-
variate analysis, intraoperative judgment errors led to in-
creased PE (PE þ 0.87; P ¼ .03).
Impact of errors on stage 1 outcomes. Table 3 presents
univariate and multivariate risk factors for strategy failure
after stage 1. The occurrence of any type of error during
stage 1 resulted inmore than twice the risk of strategy failure
with a high degree of significance and reliability (P¼ .0009;
76%) in risk-adjusted models. Postoperative errors were the
most important and remained strong, reliable, and indepen-
dent determinants of strategy failure even after adjusting for
patient complexity in multivariate models (P ¼ .01, 47%).
Children in whom PEs occurred exhibited decrements in
transplant-free survival of approximately 15% (Figure 2,
A). In risk-adjusted models, foreseeable PEs are the mostdiovascular Surgery c Volume 145, Number 6 1467
TABLE 1. Prevalence of errors occurring around the stage 1 procedure
Error
Prevalence overall (N ¼ 191) Prevalence (%)
PN % Failure (N ¼ 56) Success (N ¼ 135)
Any stage 1 error 111 58 75 51 .002
Preoperative stage 1 error 10 5 7 4 .48
Relating to pre-stage 1 intervention 5 3 4 2 .63
Relating to co-diagnosis 2 1 0 2 .36
Intraoperative stage 1 error 84 44 57 39 .025
Error in judgment 25 13 23 9 .017
Technical error 65 34 38 33 .62
Error in monitoring or assessment* 3 2 4 1 .21
Error relating to pulmonary arteries 10 5 9 4 .16
Error constructing systemic-pulmonary shunt 21 11 13 10 .80
Incorrect shunt size 6 3 7 1 .06
Arch stenosis or obstruction 11 6 11 2 .02
Error relating to coronary arteries 7 4 4 4 .96
Error relating to pulmonary veins 2 1 2 1 .50
Error relating to hemostasis 4 2 0 3 .33
Error relating to ductus 4 2 0 3 .33
Inappropriate sternal closure 10 5 5 5 .96
Ineffectual de-airing 2 1 2 1 .50
Postoperative stage 1 error 43 23 34 18 .022
Error in judgment 14 7 13 5 .12
Errors occurring on critical care 22 12 16 9 .22
Errors occurring on ward 4 2 5 1 .07
Errors relating to extubation 4 2 2 2 .85
Delay in response to clinical condition 16 8 13 7 .25
Inappropriate discharge from critical care 3 2 0 2 .56
Delay in readmission to critical care 2 1 2 1 .50
Premature attempt at sternal closure 11 6 11 4 .08
Error relating to lines 3 2 0 2 .56
Error relating to ECMO 2 1 4 0 .09
Error relating to anticoagulation 2 1 2 1 .50
Overall rates of stage 1 errors and comparative error rates in children who failed the univentricular strategy (death or transplantation) versus those who successfully transitioned to
stage 2. P values represent chi-square comparisons of proportions. Bold indicates variables with a P value of<.1 that were entered into the regression model. ECMO, Extracor-
poreal membrane oxygenation. *Anesthetic management errors were included in this category.
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P¼ .0054). Less strong but possibly still important are sub-
categories of intraoperative errors. Intraoperative unde-
tected judgment errors were a determinant of strategy
failure on univariate analysis (PE þ 1.05; P ¼ .0013), as
were detected technical errors (PE þ 0.83; P ¼ .0086).
Viewed in total (multivariate analysis), intraoperative tech-
nical errors (the most prevalent type of stage 1 error) were
not associated with increased risk of strategy failure, which
suggests that important technical errors—resulting in highly
hemodynamically significant lesions—were recognized and
addressed at the operation (eg, aortopulmonary connection–
related coronary malperfusion, major shunt flow issues, and
significant arch obstruction).
Complexity and errors. Because PEs were strong and re-
liable determinants of poor outcome, we sought predictors
of these PEs. Aortic atresia (P¼ .009), presence of bilateral
superior vena cavae (P ¼ .02), multiple cardiopulmonary
bypass runs (P ¼ .04), and intraoperative judgment errors1468 The Journal of Thoracic and Cardiovascular Sur(P ¼ .04) were all important predictors that PEs would oc-
cur, even in multivariate risk-adjusted models. Therefore,
more complex morphologic substrates and errors in surgical
judgment seem to contribute to a high likelihood of inten-
sive care errors and elevated risk of strategy failure.
Clinical estimation of errors’ importance. With regard
to the clinical importance estimate of the errors at stage 1,
of the 111 errors, 74 (67%) were judged to have conferred
some level of impact on morbidity or mortality. Of these 74
recognized impacts, 24 (32%) were linked to death and
56 (75%) were linked to identifiable morbidity. In the 24
errors linked to death, the strength of the causal link was
possible in 2 (8%), a mild relationship to death was deemed
to have occurred in 13 (54%), and a direct relation occurred
in 9 (38%).
Impact of errors on speed of recovery. Although intrao-
perative technical errors did not increase the risk of strategy
failure, their occurrence was an important determinant of
stage 1 recovery to discharge from an ICU or a hospital.gery c June 2013
TABLE 2. Most common errors at various time points
Most common errors
N ¼ 191Stage 1
Intraoperative judgment errors
1. Decision to close the chest with early
hemodynamic compromise
10 5%
2. Not addressing shunt inflow concern related
to particular anatomy
9 15%
3. Selecting wrong size shunt for body surface area 6 3%
Intraoperative technical errors
1. Systemic-pulmonary shunt anastomotic problem 21 11%
2. Coronary artery malperfusion 7 4%
3. Obstructive aortic arch reconstruction 11 6%
Intensive care management errors
1. Delay recognizing/managing a clinical scenario 16 8%
2. Failed attempt of delayed sternal closure 11 6%
3. Failed extubation 4 2%
Interstage at stage 2 N ¼ 134
Interstage
1. Delay to act on a restrictive atrial septum 18 13%
2. Delay in recognizing and acting on a complication 8 6%
Stage 2
Intraoperative judgment errors
1. Atrioventricular valve regurgitation left
unaddressed
1 1%
2. Pulmonary arterioplasty requiring 3 revisions 1 1%
3. Tricuspid valve replacement after 3 failed
repair attempts
1 1%
Intraoperative technical errors
1. Residual pulmonary artery stenosis 41 31%
2. Need for atrioventricular valve repair revision 5 4%
Intensive care management errors
1. Preventable cardiac arrest 6 4%
Associated with airway management issues 1 1%
Transport from operating room to ICU 1 1%
Improper chest tube management 1 1%
2. Delay performing an intervention 4 3%
ICU, Intensive care unit.
TABLE 3. Impact of stage 1 errors on risk of univentricular strategy
failure
Risk factor
Parameter
estimate P % Reliability
Univariate
Any stage 1 error þ1.06 .0009 —
Any intraoperative stage 1 error þ0.63 .022 —
Intraoperative error in judgment þ0.97 .0022 —
Total number of intraoperative
errors
þ0.36 .037 —
Any PE þ0.82 .0042 —
Aortic atresia 0.78 .0044 —
Mitral atresia 0.6 .0128 —
Double-inlet left ventricle
(protective)
2.1 .0035 —
Longer cardiopulmonary bypass
duration (min)
0.003 .0041 —
Intraoperative technical errors — NS —
Preoperative errors — NS —
Hybrid vs conventional surgery — NS —
Multivariate
Double-inlet left ventricle
(protective)
2.1 .0039 81
Longer cardiopulmonary bypass
duration (min)
þ0.003 .0097 55
Any PE þ0.71 .0124 47
Univariate and multivariate predictors of strategy failure (death or referral for cardiac
transplantation) after stage 1 (N ¼ 191). PE, Postoperative error; NS, not significant.
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in hospital discharge of more than 3 weeks versus when
technical errors did not occur (P ¼ .0024).Stage 2
Stage 2 (N ¼ 134) was undertaken at a mean age of 5.7
months and included bidirectional cavopulmonary connec-
tion (N ¼ 89, 66%), hemi-Fontan (N ¼ 11, 8%), and com-
prehensive hybrid stage 2 (N ¼ 30, 22%). In-hospital
mortality at stage 2was 4% (N¼ 6/134). Subsequent to stage
2, 14 children (10%) died and 5 children (4%) were referred
for transplantation.At latest follow-up, 14% of childrenwho
underwent stage 2 had failed the univentricular strategy.
Interstage errors. Of the 134 children who successfully
transitioned to stage 2, 29 (22%) were subject toThe Journal of Thoracic and Carmanagement errors during the interstage period (between
stage 1 discharge and admission for stage 2). Most of these
errors were a delay to act on a restrictive atrial septum
(N ¼ 18/134; 13%) or a delay in recognizing and acting
on a complication (N ¼ 8/134; 6%). All restrictive atrial
septum errors were hybrid strategies.
Impact of interstage errors. Errors sustained during the
interstage time frame did not seem to influence the risk of
failure. Nevertheless, interstage errors significantly delayed
recovery after stage 2: ICU discharge was 16 days versus 7
days (P<.0001), and hospital discharge was 30 days versus
17 days (P<.02).
Stage 2 errors. At the time of stage 2, errors occurred in 66
of the 134 patients (49%), a similar error prevalence to
stage 1 (Table 4). Three patients (2%) presented with a pre-
operative error: unrecognized respiratory infection, perfor-
mance of an early bidirectional cavopulmonary shunt in the
presence of bilateral superior vena cavae, and known atrio-
ventricular valve regurgitation that was not addressed. The
majority of errors at the time of stage 2 also occurred intra-
operatively (N¼ 61; 46%); only 11 infants (8%) sustained
postoperative stage 2 errors. Most common errors are pre-
sented in Table 2. In the intraoperative period, judgment
errors occurred in 3 patients (2%), and technical errors
occurred in 58 patients (43%). Judgment errors were atrio-
ventricular valve regurgitation left unaddressed, a pulmo-
nary arterioplasty requiring 3 revisions, and a tricuspiddiovascular Surgery c Volume 145, Number 6 1469
FIGURE 2. A, Impact of PEs on risk of univentricular strategy failure af-
ter stage 1. Actuarial freedom from interstage failure (death, cardiac trans-
plantation, or listed for cardiac transplantation) after stage 1 in all 191 study
patients, stratified by whether a PE occurred (N¼ 43) or did not (N¼ 148).
The occurrence of a PE more than doubled the likelihood of univentricular
strategy failure. B, Impact of PEs on risk of univentricular strategy failure
after stage 2. Actuarial freedom from failure (death, cardiac transplanta-
tion, or listed for cardiac transplantation) after stage 2 in all 134 patients
who underwent partial cavopulmonary connection, stratified by whether
a PE occurred (N ¼ 11) or did not (N ¼ 123). The occurrence of a PE
more than trebled the likelihood of univentricular strategy failure. Lines
represent Kaplan–Meier estimates at the time of each event (circles).
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important technical errors were residual pulmonary artery
stenosis (N ¼ 41; 31%) and the need for atrioventricular
valve repair revision (N¼ 5; 4%). Of the postoperative pul-
monary artery stenosis issues, 20 occurred among the 100
Norwood procedures (20%) and 21 occurred among the
34 hybrid procedures (62%). In the postoperative period,
6 patients (4%) had a cardiac arrest, which was related to
airway management issues in 4 (3%). Four other patients
(3%) had a delay in performing an intervention. Of the
11 PEs, 6 (4%) were determined to be related to judgment
and 5 (4%) were related to management strategy. Seven of
the 11 patients had a preceding intraoperative error (64%).
Impact of errors on outcomes after stage 2. Risk factors
for failure after stage 2 are shown in Table 5. Errors1470 The Journal of Thoracic and Cardiovascular Suroccurring at stage 1 did not have significant repercussions
on failure after stage 2. Intraoperative errors at stage 2
also did not compromise outcomes. However, as was the
case for stage 1, PEs at stage 2 were important and reliable
determinants of death or transplant (PE þ 2.9, P ¼ .0016,
76% reliability). Therefore, despite the low prevalence of
postoperative stage 2 errors (only 8%), their impact on
strategy failure is marked. The occurrence of PEs at the
time of stage 2 led to a decrease in late strategic success
of approximately 20% (Figure 2, B). The small number
of errors after stage 2 did not allow strong assertions regard-
ing intraoperative error rescue and PE foresight.
Clinical estimation of errors’ importance at stage 2. With
regard to the estimate of clinical importance of the 66 errors
at stage 2, 41 (66%) were judged to have conferred some
impact on morbidity or mortality. Four errors (10%) were
linked to death, and 38 errors (93%) were linked to identifi-
able morbidity. The errors linked to death were thought to be
related in 1 patient, mildly related in 2 patients, and directly
related in 1 patient.
Error Rates: Conventional Norwood Versus Hybrid
Both Norwood and hybrid strategies were associated
with a high rate of error at the time of stage 1, although
this rate was significantly higher with Norwood surgery
(65% vs 40% respectively, P ¼ .001). This difference
was especially marked for intraoperative errors
(P< .0001). However, this trend was reversed at stage 2,
where errors were then significantly more prevalent among
hybrid approaches (74% vs 41%, P ¼ .0014), particularly
intraoperative technical errors (P¼ .0012). Overall, neither
early nor late freedom from strategy failure was different
between hybrid and conventional Norwood approaches.
Impact of Errors on Overall Strategy Failure
Children who did not experience a PE at stage 1 or 2 ex-
hibited a more than 15% higher rate of sustained strategic
success (Figure 3) (P ¼ .04). A child without aortic atresia
or bilateral superior vena cavae who is managed without
any PEs at either stage has a predicted late (>3 years)
transplant-free survival of more than 80%.
DISCUSSION
This study shows that themajority of children undergoing
staged palliation for HLHS experience perioperative errors.
Important determinants of adverse events, in all fields of
medicine, are diseases that have high complexity and com-
plex treatments. Although not all adverse events are caused
by medical error, most have been identified as prevent-
able.1,12,13 All surgical options for HLHS and physiologic
equivalents represent complex surgical interventions for
a complex anatomy and physiology. The resulting stage 1
balanced circulation leaves little room for tolerance of the
high physiologic demands on the single ventricle. Thisgery c June 2013
TABLE 4. Prevalence of errors occurring around the stage 2 procedure (N ¼ 134)
Error
Prevalence overall (N ¼ 134) Prevalence (%)
PN % Failure (N ¼ 19) Success (N ¼ 115)
Any interstage error 21 16 5 17 .31
Error in clinical management 18 13 5 15 .46
Error in judgment 2 1 0 2 .56
Any stage 2 error 66 49 63 47 .22
Intraoperative stage 2 error 61 46 58 43 .32
Error in judgment 3 2 5 2 .37
Technical error 58 43 53 41 .46
Error relating to AV valve 5 4 5 3 .54
Error relating to coronary arteries 1 1 0 1 .68
Error relating to pulmonary arteries 41 31 32 30 .92
Error relating to SVC 3 2 5 2 .37
Sternal reentry error 3 2 5 2 .37
Phrenic nerve palsy 2 2 0 2 .56
Postoperative stage 2 error 11 8 21 6 .05
Error in judgment 6 4 21 2 .004
Error occurring on critical care 5 4 0 4 .36
Error occurring on ward 0 — — — —
Overall rates of stage 2 and interstage errors and comparative error rates in children who failed the univentricular strategy (death or transplantation) versus those who successfully
transitioned to stage 2. P values represent chi-square comparisons of proportions. Bold indicates P values .05 that were considered significant. AV, Atrioventricular; SVC,
superior vena cava.
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impact of errors among these surgically palliated infants.
Regardless of the surgical option chosen, hundreds of
operative and intensive care maneuvers and decisions are
required for each patient. Each decision or intervention is
a point of patient risk. Because known risk factors for
survival in surgically palliated patients with HLHS are
often immutable morphologic or functional variables,2,3,14
we hypothesize that quantitative understanding of error
data could identify target areas where improvement mightTABLE 5. Impact of errors on risk of strategy failure after stage 2
Risk factor
Parameter
estimate P % Reliability
Univariate
Any postoperative stage 2 error þ1.5 .0079 —
PE in judgment þ2.44 <.0001 —
Double-inlet left ventricle
(protective)
1.99 .054 —
Hemi-Fontan þ0.99 .078 —
Younger age at stage 2 þ0.01 .0033 —
Urgent or emergency stage 2 þ1.6 .0011 —
Errors occurring during stage 1 — NS —
Errors occurring during interstage
period
— NS —
Hybrid stage 2 vs conventional — NS —
Multivariate
Younger age at stage 2 .017 .0019 77
Any PE at stage 2 þ1.9 .0016 76
Hemi-Fontan þ1.32 .0259 50
Univariate and multivariate predictors of strategy failure (death or referral for cardiac
transplantation) after stage 1 (N ¼ 134). NS, Not significant; PE, postoperative error.
The Journal of Thoracic and Carbe sought. Understanding and defining patterns for points
of risk for error allow such a process while still
recognizing that there can be ‘‘inevitability’’ about error
that the present level of expertise and technology may not
be able to mitigate.
Preoperative Errors
Preoperative errors were rare and had no discernible
impact on survival.
Intraoperative Errors
Intraoperative errors were identified in approximately
half of the patients. Univariate analysis demonstrated thatFIGURE 3. Benefit conferred by avoiding PEs at stage 1 and 2 proce-
dures. Actuarial transplant-free survival for all 191 study patients, stratified
by whether any type of PE occurred at any time (N ¼ 54) or did not
(N ¼ 137). Lines represent Kaplan–Meier estimates at the time of each
event (circles).
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Dintraoperative judgment errors led to a decrease in strategy
success. In the multivariate model, they were linked to
increased PEs. As a whole, intraoperative technical errors,
although frequent, did not directly affect strategy survival.
One potential reason is an institutional policy of assessing
repair quality in the operating room using echocardiogra-
phy. Aortic arch obstruction, coronary malperfusion, and
aortopulmonary connection problems are immediately
addressed. It was our intentional plan to eliminate lethal
residual anatomic problems at the time of the original oper-
ative setting even if additional aortic crossclamp and cardio-
pulmonary bypass time was required. Less important
anatomic problems may have only become evident in the
postoperative timeframe. They were identified as residual
lesions but flagged as an intraoperative error because they
were considered the result of a less than optimal technical
performance. These problems, such as mild pulmonary ar-
tery and shunt stenosis, might not be immediately noticed
in the operating room because of the fidelity of imaging
or the hemodynamic repercussions of general anesthesia,
but still may have physiologic impact.15 Altogether, this un-
derlines the importance of a good-quality repair as noted by
other authors.16-18 Bacha and colleagues16 used predis-
charge echocardiography as a surrogate for intraoperative
technical performance. They showed that residual lesions
negatively affect patients’ outcome. Bacha and colleagues’
study and this study are not contradictory. For example,
when examining patient-specific, known operative risks of
longer and multiple bypass runs, incremental risk to strat-
egy failure remains a consequence in a multivariate model,
that is, technical performance still matters to survival. A
less than optimal technical performance also makes postop-
erative care more difficult as manifest by the linkage to
increased PE. Clearly, what transpires in the operating
room is important to the level of illness and survival.
Postoperative Errors
PEs were the most important determinants of failure in
this study. Patient-specific factors, such as aortic atresia or
bilateral superior vena cavae influenced survival. After
accounting for patients’ risk status, PEs remained robust
independent predictors of poor outcome. This fact is impor-
tant, because it implies that postoperative management
errors are not solely a function of patient complexity. How-
ever, patient complexity is also important given that the
identified patient-specific risk factors also lead to a higher
risk of error in critical care. This simply illustrates that
more complex cases have a higher risk for error in manage-
ment.1 A more specific concern regarding postoperative
care is that it can be difficult to fully appreciate a patient’s
change in a fragile condition. This is highlighted by the fact
that delays of recognizing and managing postoperative clin-
ical scenarios constituted a large part of errors that occurred
in the critical care unit. The recognition issues arise from1472 The Journal of Thoracic and Cardiovascular Surthe fidelity of diagnostic tools and the insidious pattern of
presentation evolving over the postoperative recovery that
can be counted in days and weeks.15-18
Interlinkage Between Errors
Results show that intraoperative errors increase intensive
care and hospital length of stay. In other words, intraoperative
errors lengthen the exposure time for PEs to occur. Reason19
and Cartney and colleagues20 term this ‘‘latent failure,’’ which
can be further illustrated by the conceivable scenario of both
a judgment error and a technical error occurring in the operat-
ing room.Neithermight be significant enough tobe recognized
at the time but could alter the ability of the patient to copewith
later stress or management error.13,20 The latent effect can be
seen clearly with interstage errors, where there was not a risk
to failure of strategy, but there was a significant impact on
the length of hospital stay during stage 2.
Importance of the Hinge Points
Important areas of risk for error are transition points from
one level of risk and monitoring to another, for example,
chest closures, extubations, transfers out of the ICU, and
hospital discharges. These ‘‘hinge points’’ are recognized
sources of error in intensive care and may represent overall
level of illness and complexity or even ‘‘flare up’’ of latent
failures that occurred previously in the preoperative, intra-
operative, and earlier postoperative periods.21-24 They also
frequently involve decisions of expert judgment for
patients who are physiologically marginal, for example,
chest closure may occur in the ICU (a surgical and
medical decision combined) but may fail and lead to
worsening of the already marginal condition. Clearly
defined guidelines and protocols for managing these
transitions may improve the incidence of unfavorable
decisions and interventions. At a minimum, protocols
would allow for data-driven attempts at improving error
incidence and allow for differentiation between a protocol
error and a ‘‘normal course’’ adverse event. Hinge points
represent an area for potential improvement. Further inves-
tigations should be devoted to better define these transitions
in care and physiology, as well as to make these transitions
better tolerated by these fragile patients.
Hybrid Versus Norwood
Some institutions reserve the use of the hybrid strategy
for some defined anatomic variants, whereas at The Hospi-
tal for Sick Children hybrid stage 1 and Norwood stage 1
procedures are used for all the variants of HLHS. The pat-
tern of error is different in the Norwood and hybrid proce-
dures. For Norwood procedures, errors predominate
during stage 1. For hybrid procedures, errors are more prev-
alent during stage 2. Overall survival for the 2 strategies was
similar. Of note, an important difference between the 2
strategies is the prevalence of residual pulmonary arterygery c June 2013
Jacques et al Congenital Heart Diseasestenosis in stage 2 conventional strategies (20%) versus that
in hybrid stage 2 strategies (62%). The long-term impact on
the Fontan circulation remains to be determined.C
H
DStudy Limitations
Medical errors are difficult to accurately identify. We
attempted to use a thorough and introspective approach. Iron-
ically, we could err in our estimate of error and may have
overestimated its occurrence, although the literature would
suggest that we would underestimate it.25 The indistinct dif-
ference between ‘‘errors’’ and some ‘‘complications’’ is also
challenging. Leape and colleagues1 report that the line be-
tweenpreventable errors and ineluctable complications along
the spectrumof adverse events is amoving target that evolves
with increasing knowledge, that is, ineluctable complications
of today may become known as medical errors tomorrow. In
quality assessment and safety literature, it is recognized that
complications are too frequently regarded as being immuta-
ble and underreported, especially those occurring during pro-
longed hospitalization.25 Self-fulfillment, a situation in
which avoiding gaps in performance is not possible because
of preceding events, is another limitation. Errors are interde-
pendent and act synergistically on outcomes, and their intrin-
sic effect is sometime difficult to circumscribe.
Although the entire documented patient course was
assessed through stage 2, transplantation, or death, some
errors could have been missed because of a lack of docu-
mentation or granularity in documentation. This study is
an initial attempt at understanding error in this cohort. Pro-
spective evaluation will lead to enhanced understanding,
particularly with respect to work organization such as lead-
ership, hierarchy, and communication. A third-party con-
current observation would be of particular value.CONCLUSIONS
In this study, the majority of children with HLHS and
physiologic equivalents who underwent surgical palliation
had an occurrence of medical error. Errors were most com-
mon in the intraoperative or postoperative windows. Tech-
nical intraoperative errors delayed patient recovery but
did not influence the risk of strategy failure (likely because
lethal errors were corrected in the same operative setting).
Intraoperative judgment errors affected survival in a univar-
iate analysis and led to increased PEs in a multivariate
model. PEs were reliable determinants of strategy failure
in a multivariable model. The occurrence of a PE decreases
transplant-free survival by 15% to 20%. Understanding
patterns of errors and using strategies to decrease errors
hold the possibility of improving patient outcome.References
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Discussion
Dr Emile Bacha (New York, NY). I have to compliment you and
Dr Van Arsdell on a courageous study. It is never easy to admit
having made a mistake, especially if a patient’s life is on thediovascular Surgery c Volume 145, Number 6 1473
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Dline. However, it is also the first step toward learning from our mis-
takes, and you could call it a first step toward redemption. In fact,
past errors properly documented can be seen as a form of negative
knowledge.
Studies in the field of action science such as this one are difficult
because they are inherently subjective. This leads me to my first
question. How were the errors adjudicated? Was it by expert con-
sensus or a single physician?
Dr Jacques. That is correct. For a contextual explanation, the
multidisciplinary senior authors had previously performed a con-
sensus-based review for 10 years of our institutional congenital
cardiac surgery–related mortality. Through that process we had
achieved a standardized approach for identifying and labeling er-
ror and thus were comfortable with the single senior review. This
study was a subsequent study that looked not only at mortality (nu-
merator) but also at the survivors (denominator) so that there could
be a better understanding of the relation between all errors identi-
fied and their potential impact on outcomes.
Dr Bacha. So it was a single person, not a group of experts,
deciding what was an error and what was not, correct?
Dr Jacques. Correct, but based on the methodology, that was
including critical care and cardiology staff.
Dr Bacha. That is certainly one weakness of the study. How do
you explain the seemingly contradictory information of the high
stage 1 intraoperative error rate of 58%, a high percentage of which
was not detected; by your own article, 84% of judgment errors
were not detected in the operating room, and 63% of technical
errors were not detected, yet you have an acceptable operative
mortality of 16% in the stage 1 operation. That is equivalent to
other large centers. How do you explain that contradiction?
Dr Jacques. Every patient has an intraoperative echocardio-
graphic evaluation in the operating room so that we can identify
any major anatomic problem, such as Damus–Kaye–Stansel
obstruction. We try to identify any occurrence of and solve all
potentially lethal anatomic problems before leaving the operating
room. I forgot the subsequent part of your question.
Dr Bacha. You have a high error rate and some recovery, but
your outcomes are good. So you are saying your recovery, that
is, your compensation mechanisms, are robust. That’s what you’re
telling us, right?
Dr Jacques. Yes. It is important to understand that a number of
minor technical issues, such as a small amount of pulmonary artery
narrowing, were identified only on postoperative studies. Because
they were less than optimal findings, they were labeled as a techni-
cal issue but stratified and estimated in the article as having no
impact on clinical outcome.
Dr Bacha. Did you stratify errors by surgeon or level of
experience?
Dr Jacques. It is a subanalysis that we are planning to do, but
not at this point.
Dr Bacha. Your errors, again, were lumped into 2 fairly wide
categories, technical or judgment for intraoperative errors and
judgment and management for PEs. Of course, there are many
types of errors. There are even specific taxonomy systems that al-
low you to place errors into specific categories, errors of omission,
observational errors, communication errors, conceptual errors, and
so forth. Would you consider reclassifying your errors in a more
granular way to be able to hone in on specific problems better?1474 The Journal of Thoracic and Cardiovascular SurDr Jacques. We used that classification to help us understand
where we might look to make improvements. It is an interesting
suggestion to look for more granular data; however, it is important
to understand that some errors, such as communication errors,
might be difficult to identify through a chart review.
DrCraig Smith (NewYork, NY). If I worked in your ICU, I think
Iwould be tempted to askwhether this is an exercise in blame-shift-
ing, and I think there is an issue here that I may not be smart enough
to understand statistically. You are describing 4 sequential events,
and the fact that they are sequential might not influence the fre-
quency of events in each episode, but it does seem to me possible
that it would push the impact downstream and make anything
that happens in the fourth episode appear more important than
the things that happened previously. You touch on that possibility
in demonstrating the high interrelatedness between factors, but I
wonder if multivariable analysis is an adequate method for sorting
out the sequential dependencyof early events on subsequent events.
Did you go through this with your statistician?
Dr Jacques. First, it is important to note that this study is not
meant to assign blame. We didn’t know this was going to be the
finding of our study. Outcomes have been fairly steady for 10 or
more years in this vulnerable physiology.Wewanted to see if there
were areas where we, as a team, could improve performance and
thereby potentially enhance outcomes. In our estimate, the best
way to approach this was to look broadly, with respect to time,
areas of care, and definition of optimal.We are sensitive to the con-
cept that this can be viewed as finger pointing. We would note that
the surgeons are actively involved with the decision-making and
interventions during the postoperative intensive care phase—it is
a team effort. Further, a large number of the postoperative identi-
fied errors had to do with decision-making around chest closure
(a surgical decision). The statistical analysis included preopera-
tive/intraoperative information and PEs and was designed to iden-
tify independent factors associated with poor outcome. It could be
that we are solving most of the life-threatening errors in the oper-
ating room by actively addressing echocardiogram-identified
problems at the time. These patients are then rescued but have
a propensity for more postoperative management challenges
because they arrive in a less healthy state of physiology.
Dr Thoralf Sundt (Boston, Mass). I have a concern about your
definition of error and the possibility that you have essentially con-
taminated it with the outcome. This raises potential for confusion
between the occurrence of an error and the occurrence of an
adverse outcome. For example, in an early slide you said you
defined it as an error if the patient was over-anticoagulated and
bled. But isn’t it an error if the patient is over-anticoagulated
regardless of whether he/she bleed, whether there is an adverse
event or not? The importance of this distinction is that if you con-
nect the 2, if you require adverse event in the definition of error,
then your result is a fait accompli; you are destined to show a rela-
tionship between errors and outcomes, which is the principal
finding of your study.
Dr Jacques. This is an important point. We looked for adverse
events that occurred outside of the usual course of the treated dis-
ease. We then determined if these had been affected by a clinical
decision or intervention and if the adverse event was controllable
or uncontrollable. If the event was not controllable, it was consid-
ered a natural complication and not labeled an error. Those thatgery c June 2013
Jacques et al Congenital Heart Diseasewere controllable were considered an error. This is in line with the
seminal publication of Leape and colleagues 20 years ago.
Dr Paul Kirshbom (Atlanta, Ga). I was wondering with this very
nongranular presentation if more granular analysis of your data pre-
sented you with any opportunities to take action. Did you identify
acommonality inyour ICUerrors, forexample,drugdelivery ina large
majority that could be affected by a change in your drug-delivery sys-
tem or any other commonality you could change in the future?
Dr Jacques. Yes, we have identified areas to target. That was
the ultimate goal, but I haven’t been able to detail that aspect inCOMMEN
From the Harley Street Clinic, Congenital Heart Centre, London, United Kingdom.
Disclosures: Author has nothing to disclose with regard to commercial support.
Received for publication Feb 7, 2013; accepted for publication March 14, 2013;
available ahead of print April 15, 2013.
Address for reprints: Marc R. de Leval, MD, FRCS, the Harley Street Clinic, Congen-
ital Heart Centre, 84 Harley St, 2nd Floor, London W1G 7HW, United Kingdom
(E-mail: marc.deleval@hcahealthcare.co.uk).
J Thorac Cardiovasc Surg 2013;145:1475-6
0022-5223/$36.00
Copyright  2013 by The American Association for Thoracic Surgery
http://dx.doi.org/10.1016/j.jtcvs.2013.03.010
The Journal of Thoracic and Carthe presentation. In the postoperative period, ‘‘hinge points’’ are
important. We know that in the intensive care and anesthesia lit-
erature, all the transition points, such as transferring, transport-
ing, and extubating the patient, are important periods. In our
study, ‘‘hinge points of importance’’ are timing of delayed chest
closure, timing of extubation, transfer to the ward, and the
period surrounding the discharge of the patient. These are the
most important areas where we will have to focus. We are
now working on establishing guidelines to improve the care at
these points.TARY C
H
D‘‘Errare humanum est, perseverare autem diabolicum’’ —Lucius
Annaeus Seneca, 4 BC to 45 ADMarc R. de Leval, MD, FRCSMedical outcomes result from complex interactions among
3 sets of variables: those related to the diseases, those
related to the treatments, and those related to the care
providers. The majority of outcome researchers have
concentrated on illness-specific or procedural-related
variables. By and large, human factors related to the
performance of care providers have not been included in
those analyses. Yet investment in human factors has been
shown to improve safety and enhance reliability in high-
technology industries in general and aviation in particular.
High-technology medicine such as cardiac surgery shares
many properties with what is often referred to as complex
social technical systems in which performance depends
on complex individual technical and organizational factors
and their interactions.1
In this issue of the Journal, Jacques and colleagues2
investigate the impact of human errors on team performance
and outcomes of staged palliation of hypoplastic left
heart syndromes and physiologic equivalents. Repairs of
hypoplastic left heart syndromes are models of high-technology surgery par excellence. They have a low error
tolerance requiring a sophisticated organizational structure,
the coordinated efforts of multiple individuals working in
teams, and high levels of cognitive and technical performance.
The authors review the course summaries of 191 patients
undergoing operations in a single institution over a 10-year
period. Technical and judgment errors at each stage of the
Norwood strategywere extracted from these summaries. Hu-
man errors affected approximately 50% of the patients at
both stage I and II of the Norwood strategy. At stage I,
most intraoperative judgment errors are not detected at the
time of the operation. Serious technical errors are
recognized and addressed intraoperatively (30% of patients
at stage I underwent a revision of the repair). Those
revisions were not associated with an increased risk of
strategy failure (death or transplantation), but they delayed
the postoperative recovery. Judgment errors led to an
increase in postoperative errors.
Postoperative errors are the strongest and most reliable
determinants of poor outcomes. The predictors of postoper-
ative errors are the complexity of the morphologic substrate
(more complex patients have a higher risk for error in their
management), and errors in intraoperative surgical judg-
ment increase the risk of postoperative errors. The majority
of postoperative errors after stage I are foreseeable.
Intraoperative errors at stage II did not compromise
outcomes, but despite their low incidence the postoperative
errors did have an impact on outcomes.
This study conveys important messages. In the current
state of the art, the treatment of complex congenital cardiacdiovascular Surgery c Volume 145, Number 6 1475
